Länsförsäkringar

Phenaros Pharmaceuticals is a Swedish spin-off drug discovery company from Uppsala University. We employ phenomics (large-scale cell morphological profiling) in conjunction with automation and AI to discover and repurpose medications for uncommon diseases. Aside from developing an in-house drug discovery pipeline, we also form collaborations to provide access to our discovery platform.

Stendorren Fastigheter is a Sweden-based real estate company that specializes in the development, ownership, and management of industrial, logistical, and warehouse facilities, as well as office spaces. The company operates primarily in the Greater Stockholm and Mälardalen regions, with a portfolio of properties located in areas such as Högdalen, Veddesta, Upplands-Bro, Rosersberg, Enköping, Flen, and Eskilstuna. Stendorren Fastigheter focuses on providing adequate and suitable spaces to its tenants under competitive lease terms, ensuring that its facilities meet the needs of a diverse range of businesses in the logistics and industrial sectors.

Swedish Logistic Property specializes in the development and management of logistics properties throughout Sweden. The company focuses on energy efficiency and provides modern logistics solutions tailored to the needs of diverse businesses. Its portfolio features strategically located properties that facilitate efficient logistics and supply chain operations. In addition to managing existing assets, Swedish Logistic Property actively engages in the acquisition and development of new properties to expand its presence in the logistics real estate market. The company demonstrates a strong commitment to sustainability through its construction practices and the operation of its logistics facilities.

Swedish Logistic Property specializes in the development and management of logistics properties throughout Sweden. The company focuses on energy efficiency and provides modern logistics solutions tailored to the needs of diverse businesses. Its portfolio features strategically located properties that facilitate efficient logistics and supply chain operations. In addition to managing existing assets, Swedish Logistic Property actively engages in the acquisition and development of new properties to expand its presence in the logistics real estate market. The company demonstrates a strong commitment to sustainability through its construction practices and the operation of its logistics facilities.

Adenovir Pharma AB is a biotechnology company based in Helsingborg, Sweden, focused on developing treatments for infectious diseases affecting the eyes, specifically epidemic keratoconjunctivitis (EKC). Founded in 2008 by researchers from the Department of Virology at Umeå University and P.U.L.S. AB, the company operates within the Medicon Valley, a prominent biotechnology region in Europe. Adenovir Pharma is engaged in the development of a topical antiviral pharmaceutical product aimed at treating and preventing adenoviral conjunctivitis and EKC. The company's initial research has been conducted in collaboration with the University of Lund and external service providers, utilizing unique patented technology and proprietary product concepts. By addressing a significant medical need, Adenovir Pharma seeks to provide effective treatment options for patients and create business development opportunities within the pharmaceutical industry.